Elevated FBXO10 expression levels were notably observed across various clinicopathological parameters, including tumor stage, ethnicity, sex, age, body weight, histological grade, tumor histology, lymph node metastasis status, and TP53 mutation profile (Figure 2). Here, FBXO10 is linked to neoplasm.